Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -7,955 | -7,381 | -2,459 | -595 |
| Depreciation Amortization | 692 | 188 | 140 | N/A |
| Other Working Capital | 35 | 2,051 | 641 | -756 |
| Other Operating Activity | 1,436 | 4,161 | 110 | -242 |
| Operating Cash Flow | $-5,793 | $-981 | $-1,567 | $-1,593 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 536 | 767 | 400 | N/A |
| Debt Repayment | -215 | N/A | N/A | N/A |
| Common Stock Issued | 5,972 | 255 | N/A | N/A |
| Common Stock Repurchased | -167 | N/A | N/A | N/A |
| Other Financing Activity | 83 | 0 | 1,222 | 1,593 |
| Financing Cash Flow | $6,210 | $1,022 | $1,622 | $1,593 |
| Beginning Cash Position | 96 | 55 | N/A | N/A |
| End Cash Position | 513 | 96 | 55 | N/A |
| Net Cash Flow | $417 | $41 | $55 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -5,793 | -981 | -1,567 | -1,593 |
| Free Cash Flow | -5,793 | -981 | -1,567 | -1,593 |